Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy

AIMS: We sought to clarify the role of ventriculo–arterial (V–A) coupling in the treatment of nonischemic dilated cardiomyopathy (NIDCM) by adding a mineralocorticoid receptor antagonist (MRA) to conventional anti‐failure therapy. METHODS AND RESULTS: We employed cardiac magnetic resonance imaging t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:ESC Heart Fail
Auteurs principaux: Lawson, Mark A., Hansen, David E., Gupta, Deepak K., Bell, Susan P., Adkisson, Douglas W., Mallugari, Ravinder R., Sawyer, Douglas B., Ooi, Henry, Kronenberg, Marvin W.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2021
Sujets:
Original Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006677/
https://ncbi.nlm.nih.gov/pubmed/33403831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13161
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires